You are here:--
Antibacterial drugs: Clinical development for non-developers
Part 1: Traditional development – tiers A and B


Antibacterial drugs: Clinical development for non-developers
Part 1: Traditional development – tiers A and B

REVIVE Webinar Series:

Antibacterial drugs: clinical development for non-developers

Part 1: Traditional development – tiers A and B

Speaker: David Shlaes – Antiinfectives consulting, retired

Moderator: Laura Piddock – Head of Scientific Affairs, GARDP

In this presentation we introduce the relationship between the discovery phase and later clinical development. We discuss in some depth traditional clinical development pathways (tiers A and B) focusing on the non-inferiority trial design.


We hosted a live webinar with David Shlaes and Laura Piddock on June 13, 2018, 17:00-18:30 CEST. You can watch the recording below.

If you have questions or comments, please let us know. Do so by posting them in our forum or submitting them via the ‘Talk to an expert’ feature. You can also send questions to: info.revive@dndi.org.

2018-07-06T11:49:40+00:00